REGENERON PHARMACEUTICALS INC
REGENERON PHARMACEUTICALS INC
Acción · US75886F1075 · REGN · 881535 (XNAS)
Resumen Indicadores financieros
494,00 USD
2,26 % 10,93 USD
NASDAQ (XNAS) · Precios actuales y gráficos en MoneyPeak
06.06.2025 20:42

Cotizaciones actuales de REGENERON PHARMACEUTICALS INC

BolsaTickerMonedaÚltima operaciónPrecioVariación diaria
XNAS: NASDAQ
NASDAQ
REGN
USD
06.06.2025 20:42
494,00 USD
483,07 USD
+2,26 %
XLON: London
London
0R2M.L
USD
06.06.2025 15:13
496,04 USD
483,07 USD
+2,68 %

Rendimiento

Día Semana Mes 3 meses 6 meses 1 año 5 años
0,00 % 0,55 % -11,55 % -29,27 % -36,39 % -50,84 % -17,25 %

Perfil de la empresa para REGENERON PHARMACEUTICALS INC Acción

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma;Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration and license agreements with Sanofi; Bayer; Teva Pharmaceutical Industries Ltd.; Mitsubishi Tanabe Pharma Corporation; Alnylam Pharmaceuticals, Inc.; Roche Pharmaceuticals; and Kiniksa Pharmaceuticals, Ltd., as well as has an agreement with the U.S. Department of Health and Human Services, as well as with Zai Lab Limited; Intellia Therapeutics, Inc.; Biomedical Advanced Research Development Authority; and AstraZeneca PLC. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.

Fondos invertidos

Los siguientes fondos han invertido en: REGENERON PHARMACEUTICALS INC invertido:

Fondo
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. en millones
2.094,68
Porcentaje (%)
4,91 %
Fondo
iShares Edge MSCI USA Minimum Volatility ESG UCITS ETF USD (Acc)
Vol. en millones
23.196,45
Porcentaje (%)
1,33 %
Fondo
iShares Edge MSCI World Minimum Volatility UCITS ETF EUR Hedged (Acc)
Vol. en millones
1.295,63
Porcentaje (%)
1,25 %
Fondo
iShares Edge MSCI World Minimum Volatility UCITS ETF USD (Dist)
Vol. en millones
33,86
Porcentaje (%)
1,25 %
Fondo
iShares MSCI World Health Care Sector UCITS ETF USD (Dist)
Vol. en millones
3.294,59
Porcentaje (%)
0,90 %

Datos de la empresa

Nombre REGENERON PHARMACEUTICALS INC
Empresa Regeneron Pharmaceuticals, Inc.
Símbolo REGN
Sitio web https://www.regeneron.com
Mercado principal XNAS NASDAQ
WKN 881535
ISIN US75886F1075
Tipo de valor Acción
Sector Healthcare
Industria Medical - Pharmaceuticals
CEO Dr. Leonard S. Schleifer M.D., Ph.D.
Capitalización de mercado 60 Mrd.
País Estados Unidos de América
Moneda USD
Empleados 15,1 T
Dirección 777 Old Saw Mill River Road, 10591-6707 Tarrytown
Fecha de OPV 2014-11-05
Dividendos de 'REGENERON PHARMACEUTICALS INC'
Fecha ex-dividendo Dividendo por acción
20.05.2025 0,88 USD
20.02.2025 0,88 USD

Símbolos de cotización

Nombre Símbolo
Frankfurt RGO.F
London 0R2M.L
NASDAQ REGN

Otras acciones

Los inversores que tienen REGENERON PHARMACEUTICALS INC también tienen las siguientes acciones en su cartera:
ADOBE INC
ADOBE INC Acción
ALPHABET INC - CLASS A
ALPHABET INC - CLASS A Acción
AMAZON.CO INC
AMAZON.CO INC Acción
APPLE INC
APPLE INC Acción
FORUM ENERGY TECHNOLOGIESLOGIES INC
FORUM ENERGY TECHNOLOGIESLOGIES INC Acción
HAWK IN.SOF. 25/29 FLR
HAWK IN.SOF. 25/29 FLR Bono
INTEL CORP
INTEL CORP Acción
ISHARES 0-3 MONTH TREASURY BOND ETF
ISHARES 0-3 MONTH TREASURY BOND ETF ETF
META PLATFORMS INC
META PLATFORMS INC Acción
MICROSOFT CORP
MICROSOFT CORP Acción
NVIDIA CORP
NVIDIA CORP Acción
SPDR SELECT SECTOR FUND - HEALTH CARE
SPDR SELECT SECTOR FUND - HEALTH CARE ETF
TESLA INC
TESLA INC Acción
VERTEX PHARMACEUTICALS INC
VERTEX PHARMACEUTICALS INC Acción
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras. Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Aviso legal Protección de datos Blog Comunidad Comentarios Changelog
Im App Store herunterladen Bei Google Play herunterladen
Todos los derechos reservados © LCP GmbH 2025